The role of aspirin in post-polypectomy bleeding--a retrospective survey.

BMC Gastroenterol

Gastroenterology Unit, Southern District Health Board, Dunedin, New Zealand.

Published: October 2012

Background: Bleeding following colonoscopic polypectomy is a common complication and has been reported to occur in up to 6.1% of patients. Several risk factors have been discussed but their overall contribution to post-polypectomy bleeding remains controversial. The aim of the study was to determine the rate of post polypectomy bleeding and to analyse the role of potential risk factors especially the role of aspirin.

Methods: We conducted a retrospective cohort study of all patients who underwent polypectomy at Dunedin Hospital, New Zealand between January 2007 and June 2009.

Results: During the study period, 514 patients underwent colonoscopy with polypectomy and a total of 1502 polyps were removed. From further analysis we excluded 21 patients; 15 patients had surgery immediately after colonoscopy for the diagnosis of colorectal carcinoma and 6 patients presented with symptoms of an acute lower gastrointestinal bleed prior to colonoscopy. Of the remaining 493 patients, 11 patients (2.2%) presented with post-polypectomy bleeding within 30 days of the investigation of which 8 were on aspirin. In total 145 patients were taking aspirin prior to colonoscopy and 348 patients were not taking aspirin. The use of aspirin was associated with an increased prevalence of post-polypectomy bleeding (OR=6.72, 95% C.I. 1.76 to 25.7). Interestingly, the use of non-steroidal anti-inflammatory drugs (NSAIDs) was not associated with risk of bleeding after polypectomy (OR=2.82, 95% C.I, 0.34 to 23.3).

Conclusion: Our study confirmed a significantly increased risk of lower gastrointestinal bleeding following polypectomy in patients taking aspirin. We would recommend approaching the patient on aspirin coming forward for a colonoscopy with potential polypectomy with caution.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527285PMC
http://dx.doi.org/10.1186/1471-230X-12-138DOI Listing

Publication Analysis

Top Keywords

post-polypectomy bleeding
12
patients aspirin
12
patients
11
risk factors
8
patients underwent
8
patients patients
8
lower gastrointestinal
8
prior colonoscopy
8
bleeding polypectomy
8
bleeding
7

Similar Publications

: Endoscopic resection with lift polypectomy using submucosal injection (SI) for large non-pedunculated colorectal polyps is recommended to facilitate complete mucosal resection and decrease the risk of perforation; however, there are no studies comparing the safety and efficacy of large polypectomies with and without lift polypectomy. We aimed to evaluate the feasibility and safety of the polypectomy technique without SI compared to the routine use of SI. : We performed a single tertiary center retrospective study evaluating all consecutive large non-pedunculated colorectal polyps (≥20 mm) referred to expert endoscopists in polypectomy from 2018 through 2021.

View Article and Find Full Text PDF

Objectives: Patients with Peutz-Jeghers syndrome (PJS) require continuous medical management throughout their lives. However, few case series regarding the clinical course, polyp surveillance, and treatment, including endoscopic ischemic polypectomy (EIP) for pediatric patients with PJS, were reported. We analyzed the current status and clinical course of pediatric patients with PJS under the management of our institute, including those treated with EIP.

View Article and Find Full Text PDF

Post-endoscopic mucosal resection (EMR) bleeding, or clinically significant post-EMR bleeding, is influenced by factors such as polyp size, right-sided colonic lesions, laterally spreading tumors, anticoagulant use, and comorbidities like cardiovascular or chronic renal disease. The optimal prophylactic therapy for post-EMR bleeding remains unknown, with no consensus on specific criteria for its application. Moreover, prophylactic measures, including clipping, suturing, and coagulation, have produced mixed results.

View Article and Find Full Text PDF

Periendoscopic management of antithrombotic drugs: Is cold snare polypectomy the answer?

Gastroenterol Hepatol

November 2024

Gastrointestinal Endoscopy Unit, Digestive Diseases Department, Hospital Universitari i Politècnic La Fe, La Fe Health Research Institute (IISLaFe), Valencia 46026, Spain. Electronic address:

Patients undergoing colonoscopy are increasingly taking antithrombotic medication. These patients, who are generally older, also have a higher prevalence of colon polyps. Therefore, it is general practice to modify or discontinue antithrombotic treatment before colonoscopy, to reduce the risk of post-polypectomy bleeding (PPB).

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated sex-based differences in colonoscopy indications and findings by analyzing data from 287,930 colonoscopy procedures performed between 2016 and 2021.
  • Results showed that women were more likely to undergo colonoscopies due to abdominal pain, constipation, diarrhea, and anemia, while men had more procedures related to positive FOBT, rectal bleeding, and surveillance.
  • In terms of findings, men had higher rates of colorectal cancer and polyps, while women had better bowel preparation, underscoring the need for tailored approaches in diagnosing and managing gastrointestinal diseases based on sex.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!